Wockhardt Issues U.S. Recall Of Toprol ER Generic Hypertension Drug
This article was originally published in PharmAsia News
Wockhardt issued a U.S. recall of 109,744 bottles of its generic version of AstraZeneca's Toprol (metropolol) drug for treating high blood pressure, a drug made at a plant not under U.S. FDA import alerts.
You may also be interested in...
Reporting its first full quarter of financials since merging with Allergan, AbbVie will be scrutinized for whether its optimistic talk of a quick Botox rebound actually happened.
Generic OTC paracetamol and ibuprofen pack prices are gradually returning to pre-COVID levels, according to market analysts Wavedata. But a second wave could drive prices back up again.
As one of the leading players in the US, albeit with a declining core business, Sandoz is naturally watching developments from the Federal Circuit’s precedential ruling on induced infringement for carved out indications. Management discussed the topic as Sandoz reported third-quarter financials.